News | August 22, 2013

Real-time Assessment of Tumor Response Presentation Wins Innovation Competition

Award goes to Dr. Kai Chen at the 2013 SNMMI meeting

August 22, 2013 — Molecular Targeting Technologies Inc. (MTTI) announced Dr. Kai Chen of the University of Southern California was awarded the 2013 Center for Molecular Imaging Innovation and Translation (CMIIT) Young Investigator Award during the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Vancouver, Canada. Chen presented results from his study entitled: “Synthesis and evaluation of a novel bis (zinc(II)-dipicolyamine) derivative for dual-modality PET/NIRF (positron emission tomography/near-infrared flourescence) imaging of phosphatidylserine exposure.”

This real-time assessment probe can be used to monitor tumor response in as early as one day to evaluate treatment efficacy and intervene early in treatment modification. Non-invasive imaging of drug response has a significant clinical impact and can be broadly useful for monitoring numerous conditions, including cancer, cardiovascular diseases, neurology and renal diseases.

Chen, assistant professor of the department of radiology at USC said, “Novel tools to assist in the non-invasive, real-time assessment of tumor response to anti-cancer treatment are urgently needed. Our current preclinical results could lead to a robust imaging agent, offering synergistic advantages, not only to allow comprehensive collection of cell death information, but also to facilitate clinical applications of image-guided surgery.”

For more information: mic.usc.edu, www.mtarget.com

Related Content

GE Healthcare and Theragnostics Partnering on PSMA PET/CT Imaging Agent
News | Prostate Cancer | October 16, 2019
GE Healthcare and Theragnostics have entered into a global commercial partnership for a new prostate-specific membrane...
Sponsored Content | Whitepapers | Clinical Trials | October 09, 2019
A 2019 N G PX REPORT
AI Accurately Detects Key Chest X-Ray Pneumonia Findings Within 10 Seconds
News | Artificial Intelligence | September 30, 2019
Researchers from Intermountain Healthcare and Stanford University say 10 seconds is about how quickly a new system they...
AI Accurately Predicts Radiotherapy Side Effects for Head and Neck Cancer Patients
News | Artificial Intelligence | September 26, 2019
For the first time, a sophisticated computer model has been shown to accurately predict two of the most challenging...
Machine Learning Could Offer Faster, More Precise Cardiac MRI Scan Results
News | Magnetic Resonance Imaging (MRI) | September 25, 2019
Cardiac magnetic resonance imaging (MRI) analysis can be performed significantly faster with similar precision to...
Partial and Whole-Breast Radiotherapy After Lumpectomy Provide Equally Satisfying Cosmetic Results
News | Radiation Therapy | September 25, 2019
Whole breast radiation and partial breast radiation following a lumpectomy yield similar cosmetic outcomes for women...
Hippocampal Avoidance Using IMRT Now Recommended as Standard of Care for Brain Metastases
News | Radiation Therapy | September 24, 2019
Patients with brain metastases who received whole-brain radiotherapy that avoided memory-specific hippocampal neural...
High-dose Radiation Effective for Men Whose Prostate Cancer Has Spread
News | Prostate Cancer | September 23, 2019
A randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the...
An example of a treatment plan for radio-ablation of the heart to noninvasively treat cardiac arrhythmias. This concept is one of the key presentations at the 2019 ASTRO meeting. Image courtesy of Cyberheart. #ASTRO19 #ASTRO2019 #ASTRO

An example of a treatment plan for radio-ablation of the heart to noninvasively treat cardiac arrhythmias. This concept is one of the key presentations at the 2019 ASTRO meeting. Image courtesy of Cyberheart.

Feature | ASTRO | September 23, 2019
August 29, 2019 — The American Society for Radiation Oncology (ASTRO) announced th
Densitas Wins Major Procurement of Breast Density Software for DIMASOS Breast Screening Trial
News | Breast Density | September 20, 2019
Densitas Inc. announced it has won a procurement of its densitas densityai software for deployment in up to 24 breast...